The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617F. - Guerini, V.; Barbui, V.; Spinelli, O.; Salvi, A.; Dellacasa, C.; Carobbio, A.; Introna, M.; Barbui, T.; Golay, J.; Rambaldi, A. (Leukemia (08876924), 2008)